Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Pfizer (NY: PFE )

25.66 -0.51 (-1.95%)
Streaming Delayed Price Updated: 11:38 AM EST, Nov 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
99 100 Next >
A Glimpse Into The Expert Outlook On Pfizer Through 9 Analysts
Via Benzinga
2 High-Yielding Healthcare Stocks to Buy With $1,000 in July
These reliable dividend payers are no-brainer buys right now. 
Via The Motley Fool
Cyrus Taraporevala Elected to Pfizer’s Board of Directors
From Pfizer Inc.
Via Business Wire
2 Ultra-High-Yield Dividend Stocks Billionaires Are Buying Left and Right: Could They Be Smart Buys for You in July?
With an average dividend yield of about 9.8% at recent prices, even a small investment in these stocks could significantly boost your passive income stream. 
Via The Motley Fool
4 Cheap Stocks to Buy in July
All four of these stocks are trading at very intriguing valuations. 
Via The Motley Fool
High Dividend 50: Pfizer Inc.
Pfizer currently pays a quarterly dividend of $0.42, for an annualized rate of $1.68 per share. This equates to a current dividend yield of 6% for Pfizer stock. 
Via Talk Markets
This Is What Whales Are Betting On Pfizer
Via Benzinga
Is Pfizer Stock a Buy?
The stocks offers a hefty 6% dividend yield and is trading near decade lows. 
Via The Motley Fool
A Closer Look at Pfizer's Options Market Dynamics
Via Benzinga
Shhh! 7 Stocks Quietly Lining Up for a Massive Surge in July.
Uncover the next big investment opportunities with these top stocks to buy, from AI advancements to robust financial performances. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Sectors That Could Get Slammed by Attempts to Reduce U.S. Debt
With Washington likely having to take steps to cut the U.S. deficit within the next few years, here are three sectors at risk. 
Via InvestorPlace
The Top 3 Weight Loss Drug Stocks to Buy for Huge Gains
Consider buying shares in these pharma companies, each of which is a leader in the weight loss drug sector. 
Via InvestorPlace
2 Healthcare Stocks That Are Screaming Buys in June
These top healthcare stocks are no-brainer buys in 2024 and beyond. 
Via The Motley Fool
You’ve Been Warned! 3 Pharma Stocks to Buy Now or Regret Forever.
Pharmaceutical stocks can be considered risky, but when their trials get approved by FDA, the stock can go to the moon. 
Via InvestorPlace
Exposures Product Safety
3 Dividend Stocks to Buy If You Want Cash for Life
Cheap dividend stocks for cash flow are worth pursuing for investors seeking to rotate away from the red-hot AI-driven tech scene. 
Via InvestorPlace
Dow Jones Powerhouse Merck Dives On Surprise FDA Rejection
The FDA rejected Merck's Daiichi Sankyo-partnered antibody drug conjugate. 
Via Investor's Business Daily
Topics Stocks
Exposures Product Safety US Equities
This Recent FDA Approval Is Bad News for Pfizer
One of the pharma giant's top-selling products is about to face some intense competition. 
Via The Motley Fool
Exposures Product Safety
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron JN.1-adapted COVID-19 Vaccine in the European Union
From Pfizer Inc.
Via Business Wire
2 Exceptional Growth Stocks to Buy for Under $100
These beaten-down stocks may be overlooked by some investors, but that could be a golden opportunity for others. 
Via The Motley Fool
CDC Advisor Panel Recommends RSV Shots In US For People Above 75 Years, Analyst Says Decision Negative For GSK
The CDC's ACIP recommends RSV vaccines for adults 75+, and for those 60-74 with chronic conditions. GSK's Arexvy is approved for adults 50-59 at risk. A decision on adults 50-59 is pending further... 
Via Benzinga
3 Beautiful Blue-Chip Stocks You Can Buy for Less Than $100
Wise investors consider three blue-chip stocks under $100, no matter what happens during the rest of the year. 
Via InvestorPlace
2 Beaten-Down Dividend Stocks With Yields Above 5% to Buy Now and Hold at Least a Decade
High yields that could continue growing for the foreseeable future make these stocks no-brainer buys right now. 
Via The Motley Fool
2 Stocks Down More Than 30% to Buy Right Now
These stocks have suffered as the demand for their biggest product -- the coronavirus vaccine -- waned. 
Via The Motley Fool
Exposures COVID-19
Pfizer Declares Third-Quarter 2024 Dividend
From Pfizer Inc.
Via Business Wire
What's Going On With Pfizer Shares Wednesday?
Pfizer Inc. (NYSE: PFE) is experiencing notable stock movement on Wednesday afternoon. Here's what you need to know. 
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Why Is Moderna Stock Trading Lower On Wednesday?
The CDC's Advisory Committee on Immunization Practices is set to discuss recommendations for RSV, influenza, and COVID-19 vaccines. Moderna's data shows vaccine efficacy drops to 50% after 18 months in... 
Via Benzinga
Exposures COVID-19
Moderna Crumbles After RSV Vaccine Effectiveness Pales Vs. Pfizer, GSK Shots
After 18 months, Moderna's RSV vaccine proved about 50% effective against lower respiratory tract disease. 
Via Investor's Business Daily
Is Pfizer's Pain Sarepta Therapeutics' Gain? Don't Bet on It.
One company's negative results can increase scrutiny of another's work. 
Via The Motley Fool
3 Blue-Chip Stocks to Buy on the Dip: June 2024
These top blue-chip stocks to buy on the dipare proven winners offering solid long-term growth, reliable dividends and excellent value. 
Via InvestorPlace
< Previous 1 2
...
13 14 15 16 17 18 19 20 21
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.